Development of Clinical Indicators From the Swiss RAI-HC (IndiRAI)

April 11, 2023 updated by: Catherine Ludwig, School of Health Sciences Geneva

Development of Frailty and Complexity Indices From Data Collected With Resident Assessment Instrument - Home Care Adapted for Switzerland

The project aims at deriving frailty (FI) and complexity (CI) indices from data collected with the Resident Instrument Assessment - Home Care adapted for Switzerland (RAI-HC). Data were collected in 2015 by trained nurses in clinical routine with the primary purposes of health state assessment and individual home care planning. The study consists in a retrospective secondary analysis of health data from the Minimal Data Set (MDS), used to derive frailty and complexity indices according to published definitions and guidelines for index derivation. The analysis further aims at estimating the predictive power of these indices on undesirable health outcomes (falls, hospitalizations and deaths). The goal is to provide home care institutions and nurses valid algorithms to compute useful clinical indicators without additional assessment that the one routinely done with the RAI-HC.

Study Overview

Status

Completed

Intervention / Treatment

Study Type

Observational

Enrollment (Actual)

10000

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

14 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Sampling Method

Non-Probability Sample

Study Population

Adult applicants for home care services provided by imad (Geneva, Switzerland) who received a first RAI-HC assessment in 2015 for routine care planning purposes

Description

Inclusion Criteria:

  • Men and women aged 18 or older who were assessed in 2015 with the Swiss RAI-HC in clinical routine for care planning by the Geneva Institution for Home care and Assistance (imad) in Geneva, Switzerland

Exclusion Criteria:

  • Men and women aged 17 or younger and/or who did not receive a full RAI-HC assessment in 2015

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Cohort
  • Time Perspectives: Retrospective

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Frailty Index
Time Frame: 1 year
Index with a value ranging from 0 to 100, computed as the sum of health deficits recorded with the RAI-HC MDS divided by the number of deficits considered
1 year
Complexity Index
Time Frame: 1 year
Index with a value ranging from 0 to 100, computed as the sum of complexity items recorded with the RAI-HC MDS divided by the number of items considered
1 year

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Falls
Time Frame: 6 months on average
Falls recorded by means of follow-up RAI-HC assessments
6 months on average
Hospitalizations
Time Frame: 6 months on average
Hospitalizations recorded by means of follow-up RAI-HC assessments
6 months on average
Mortality
Time Frame: through study completion, an average of 5 year
Deceased (yes/no); collected through administrative records
through study completion, an average of 5 year

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Catherine Ludwig, PhD, School of Health Sciences Geneva

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 1, 2015

Primary Completion (Actual)

December 31, 2015

Study Completion (Actual)

April 11, 2023

Study Registration Dates

First Submitted

April 24, 2017

First Submitted That Met QC Criteria

May 2, 2017

First Posted (Actual)

May 3, 2017

Study Record Updates

Last Update Posted (Actual)

April 12, 2023

Last Update Submitted That Met QC Criteria

April 11, 2023

Last Verified

October 1, 2022

More Information

Terms related to this study

Other Study ID Numbers

  • 74217

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

The coded datasets supporting the findings of this study are not publicly available for they belong to imad and are not the property of the authors of the study. The data analyzed for the study could be made available from the authors upon reasonable request and with prior agreement by imad.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Frail Elderly Syndrome

Clinical Trials on Swiss RAI-HC assessment

Subscribe